Menu Search
Equities

Cambridge Cognition Holdings PLC

1M7:STU

Cambridge Cognition Holdings PLC

Actions
  • Price (EUR)0.540
  • Today's Change-0.045 / -7.69%
  • Shares traded0.00
  • 1 Year change-49.06%
  • Beta--
Data delayed at least 15 minutes, as of May 02 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Cambridge Cognition Holdings plc is a neuroscience technology company. The Company develops and markets digital solutions to assess brain health, principally in the United Kingdom, the United States and Europe. Its products include CANTAB Recruit, CANTAB Connect, Cognition Kit, Cognition eCOA, CANTAB Connect Research, CANTAB Mobile, CANTAB BrainHealth, CANTAB Insight, and NeuroVocalix. CANTAB Recruit is an online trial recruitment platform helping pharmaceutical and biotechnology companies identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease. CANTAB Connect offers digital cognitive assessment solutions for pharmaceutical clinical trials in therapeutic areas from phases I - IV. Cognition Kit is a custom-designed digital health platform delivering wearable and smartphone apps for high frequency data collection. It serves specialist contract research organizations, academic research institutions, and international healthcare providers.

  • Revenue in GBP (TTM)13.52m
  • Net income in GBP-3.51m
  • Incorporated2012
  • Employees80.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.